許凱程

Hsu, K. C., HuangFu, W. C., Lin, T. E., Chao, M. W., Sung, T. Y., Chen, Y. Y., Pan, S. L., Lee, J. C., Tzou, S. C., Sun, C. M. & Yang, J. M., 十二月 1 2020, 於 : Scientific Reports. 10, 1, 10510.

研究成果: 雜誌貢獻 › 文章

開啟存取

Corrigendum to“Isoindoline scaffold-based dual inhibitors of HDAC6 and HSP90 suppressing the growth of lung cancer in vitro and in vivo”[Eur. J. Med. Chem. 190 (2020 Mar 15) 112086] (European Journal of Medicinal Chemistry (2020) 190, (S0223523420300532), (10.1016/j.ejmech.2020.112086))

Ojha, R., Nepali, K., Chen, C. H., Chuang, K. H., Wu, T. Y., Lin, T. E., Hsu, K. C., Chao, M. W., Lai, M. J., Lin, M. H., Huang, H. L., Chang, C. D., Pan, S. L., Chen, M. C. & Liou, J. P., 九月 1 2020, 於 : European Journal of Medicinal Chemistry. 201, 112404.

研究成果: 雜誌貢獻 › 評論/辯論

Fluoropyrimidin-2,4-dihydroxy-5-isopropylbenzamides as antitumor agents against CRC and NSCLC cancer cells

Wu, W. C., Liu, Y. M., Liao, Y. H., Hsu, K. C., Lien, S. T., Chen, I. C., Lai, M. J., Li, Y. H., Pan, S. L., Chen, M. C. & Liou, J. P., 十月 1 2020, 於 : European Journal of Medicinal Chemistry. 203, 112540.

研究成果: 雜誌貢獻 › 文章

Functional analysis of Clostridium difficile sortase B reveals key residues for catalytic activity and substrate specificity

Kang, C. Y., Huang, I. H., Chou, C. C., Wu, T. Y., Chang, J. C., Hsiao, Y. Y., Cheng, C. H., Tsai, W. J., Hsu, K. C. & Wang, S., 三月 13 2020, 於 : Journal of Biological Chemistry. 295, 11, p. 3734-3745 12 p.

研究成果: 雜誌貢獻 › 文章

Investigating the potential effects of selective histone deacetylase 6 inhibitor ACY1215 on infarct size in rats with cardiac ischemia-reperfusion injury

Lin, C. F., Hsu, K. C., Huangfu, W. C., Lin, T. E., Huang, H. L. & Pan, S. L., 三月 12 2020, 於 : BMC Pharmacology and Toxicology. 21, 1, p. 21 21.

研究成果: 雜誌貢獻 › 文章

開啟存取

許 凱程

學歷

經歷

研究興趣

許凱程